Advertisement

 

 

CHA2DS2-VASc score predicts contrast induced nephropathy in patients with ST-segment elevation myocardial infarction who were undergoing primary percutaneous coronary intervention.

CHA2DS2-VASc score predicts contrast induced nephropathy in patients with ST-segment elevation myocardial infarction who were undergoing primary percutaneous coronary intervention.
Author Information (click to view)

Cicek G, Yıldırım E,


Cicek G, Yıldırım E, (click to view)

Cicek G, Yıldırım E,

Advertisement

Kardiologia polska 2017 10 05() doi 10.5603/KP.a2017.0177
Abstract
BACKGROUND
We aimed to investigate the predictive value of the CHA₂DS₂-VASc score in the development of Contrast Induced Nephropathy (CIN).

METHODS
A total of 2972 patients who had been diagnosed with ST elevation-MI and who had undergone primary coronary angioplasty were included in the study. The patients were divided into 3 groups according to the CHA₂DS₂-VASc score as low risk (1 point), intermediate risk (2 points) and high risk (≥3 points). The groups were followed-up with regard to CIN development.

RESULTS
The median CHA₂DS₂-VASc score was significantly higher in the CIN(+) groups compared to the CIN(-) group (3 vs 2, p<0.001). The rate of CIN was 3.32-fold higher in the high-risk group (CHA₂DS₂-VASc ≥3) compared to the low-risk group (CHA₂DS₂-VASc =1) (OR 3.32, p<0.001). Age (OR: 1.25, p<0.001), female gender (OR: 1.52, p<0.001), hypertension (OR: 1.50, p<0.001), peak CKMB (OR: 1.15, p<0.001) and the KILLIP score >1 (OR: 4.25, p<0.001) were found to be independent predictors for CIN development. CONCLUSIONS
The CHA₂DS₂-VASc score is an independent and strong predictor of CIN development in patients with acute ST-elevation MI.

Submit a Comment

Your email address will not be published. Required fields are marked *

12 − eleven =

[ HIDE/SHOW ]